We are live on ! Find out more
Creative Planning

Creative Planning Portfolio holdings

AUM $147B
1-Year Est. Return 18.73%
This Fund
S&P 500
This Quarter Est. Return
+5.55%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$5.86B
AUM Growth
+$813M
Cap. Flow
+$544M
Cap. Flow %
9.28%
Top 10 Hldgs %
50.44%
Holding
3,726
New
379
Increased
1,205
Reduced
834
Closed
278

Sector Composition

Rank Sector Weight
1 Energy 6.93%
2 Financials 4.55%
3 Technology 3.35%
4 Industrials 2.51%
5 Healthcare 2.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PDLI
1326
DELISTED
PDL BioPharma, Inc.
PDLI
$80K ﹤0.01%
9,476
+2,798
+42% +$23.6K
XBI icon
1327
State Street SPDR S&P Biotech ETF
XBI
$10.1B
$79K ﹤0.01%
1,830
+666
+57% +$27.6K
LMNX
1328
DELISTED
Luminex Corp
LMNX
$79K ﹤0.01%
4,050
FNFG
1329
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
$79K ﹤0.01%
7,484
-225
-3% -$2.44K
RNF
1330
DELISTED
RENTECH NITROGEN PARTNERS, L.P. INT
RNF
$79K ﹤0.01%
4,509
-9,055
-67% -$196K
BKN
1331
DELISTED
BlackRock Investment Quality Municipal Trust
BKN
$78K ﹤0.01%
5,500
-9,500
-63% -$130K
EQR icon
1332
Equity Residential
EQR
$25.4B
$78K ﹤0.01%
1,498
+270
+22% +$14.2K
FMX icon
1333
Fomento Económico Mexicano
FMX
$43.3B
$78K ﹤0.01%
792
-24
-3% -$2.26K
WTS icon
1334
Watts Water Technologies
WTS
$11.5B
$78K ﹤0.01%
1,255
DLA
1335
DELISTED
Delta Apparel Inc.
DLA
$78K ﹤0.01%
+4,600
New +$79.5K
CSFL
1336
DELISTED
CenterState Bank Corporation Common Stock
CSFL
$78K ﹤0.01%
7,658
GM.WS.B
1337
DELISTED
General Motors Company
GM.WS.B
$78K ﹤0.01%
3,395
+219
+7% +$4.46K
RXII
1338
DELISTED
GALENA BIOPHARMA INC COM
RXII
$78K ﹤0.01%
15,780
+6,500
+70% +$32.1K
GOF icon
1339
Guggenheim Strategic Opportunities Fund
GOF
$2.22B
$77K ﹤0.01%
3,585
+3,330
+1,306% +$72.6K
SGU icon
1340
Star Group
SGU
$428M
$77K ﹤0.01%
14,690
+193
+1% +$1.04K
TTC icon
1341
Toro Company
TTC
$8.93B
$77K ﹤0.01%
2,414
+2
+0.1% +$59
WTW icon
1342
Willis Towers Watson
WTW
$27.9B
$77K ﹤0.01%
651
+65
+11% +$7.68K
ATCO
1343
DELISTED
Atlas Corp.
ATCO
$77K ﹤0.01%
3,338
+166
+5% +$3.71K
WUBA
1344
DELISTED
58.com Inc
WUBA
$77K ﹤0.01%
+2,000
New +$63.4K
NPM
1345
DELISTED
NUVEEN PREMIUM INCM MUNI FD II
NPM
$77K ﹤0.01%
6,100
+2,300
+61% +$28.9K
DYAX
1346
DELISTED
DYAX CORPORATION
DYAX
$77K ﹤0.01%
10,250
BPOP icon
1347
Popular Inc
BPOP
$11B
$76K ﹤0.01%
2,634
EOS
1348
Eaton Vance Enhance Equity Income Fund II
EOS
$1.14B
$76K ﹤0.01%
5,871
-19,442
-77% -$241K
IMAX icon
1349
IMAX
IMAX
$2.38B
$76K ﹤0.01%
2,575
LNCO
1350
DELISTED
LINNCO LLC COM SHS REPSTG LTD LIABILITY
LNCO
$76K ﹤0.01%
2,469
-130
-5% -$3.98K

Similar funds

Creative Planning's Q4 2013 Portfolio in Review

As of Q4 2013, Creative Planning held 3,726 positions worth $5.86B, up 16% from $5.04B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Creative Planning deployed $544M of net new capital in Q4 2013, opening 379 new positions and adding to 1,205 existing holdings. Its largest new stake was Allergan plc: 7,924 shares worth $1.33M.

By sector, the portfolio is most concentrated in Energy at 6.9% of assets, up from 6.3% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Vanguard Intermediate-Term Corporate Bond ETF, an estimated $77.7M trimmed.

  • Creative Planning's largest Q4 2013 buy was Allergan plc: 7,924 shares worth $1.33M.
  • Creative Planning added most to Vanguard FTSE Developed Markets ETF in Q4 2013, an estimated $68.1M increase.
  • Creative Planning's biggest Q4 2013 reduction was Vanguard Intermediate-Term Corporate Bond ETF, cutting an estimated $77.7M.
  • Creative Planning fully exited Pioneer Municipal High Income Advantage Fund in Q4 2013, selling an estimated $1.95M.
  • Creative Planning's ten largest holdings make up 50% of its $5.86B portfolio in Q4 2013.
  • Creative Planning opened 379 new positions and closed 278 in Q4 2013.
  • Creative Planning's portfolio value rose 16% quarter-over-quarter to $5.86B.

Based on Creative Planning's 13F filing for Q4 2013, filed 6 Jan 2014.